Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-01-06

Clinical Trial Update: Systemic Hypothermia Improves Outcome of Hypoxic-Ischemic Encephalopathy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial data suggest systemic hypothermia may improve outcomes in Hypoxic-Ischemic Encephalopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Zhengzhou University | Conditions: Hypoxic-Ischemic Encephalopathy | Phase 1, Phase 2 | Status: COMPLETED